Company news
Ondine Biomedical, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Ondine Presents Major Economic Benefits at ICPIC
September 18, 2025
Steriwave proven to be effective against C Auris
September 15, 2025
Grant of Options
September 12, 2025
Steriwave Featured on CNBC’s Worldwide Exchange
September 10, 2025
Notification of major holdings - hInsight
September 8, 2025
Notification of major holdings - Pentwater
September 4, 2025
Ondine to present Health Economic Data at ICPIC
September 3, 2025
Total Voting Rights Correction
September 1, 2025
Result of Fundraise & TVR
August 28, 2025
Proposed c.£11m Fundraise
August 27, 2025
First Mexican Hospital Steriwave Deployment
August 13, 2025
Ex-President of Mexico Champions APDT to Cut AMR
August 11, 2025
Share Issuance for ICU Study Enrollment Completion
July 22, 2025
UK Axes Financial support for AMR Fleming Fund
July 21, 2025
Growing Use of Steriwave Across Surgery Types
July 14, 2025
Steriwave in Half of Fraser Health Hospitals
July 8, 2025
Ondine Appoints Peel Hunt as Broker
July 1, 2025
Leading Canadian Surgery Centre Adopts Steriwave
June 30, 2025
Result of AGM and voting results
June 26, 2025
Steriwave Standard of Care in 2nd Health Authority
June 25, 2025
Second Quebec Hospital Adopts Steriwave
June 19, 2025
UK Doctor Wins Award for NHS Steriwave Innovation
June 16, 2025
NHS Trust up for HSJ Award for Steriwave Use
June 12, 2025
Ondine Presents Groundbreaking Findings
June 10, 2025
UCL Shows Steriwave Effective Against Mucor Fungus
June 9, 2025
Canada's Largest Cardiac Centre Adopts Steriwave
June 5, 2025
Notice of AGM
June 4, 2025
2024 Full Year Results and Annual Report
May 15, 2025
Ondine Joins CAN Health Network
May 12, 2025
Appointment of non-Board Interim CFO
May 9, 2025
Notice of Results and Investor Presentation
May 8, 2025
Economic study suggests c.£200 million UK savings
April 9, 2025
Replacement: Steriwave in first Swiss hospital
April 8, 2025
Mid Yorkshire NHS Trust cuts SSI rates by 71%
April 2, 2025
Board Changes
March 28, 2025
Steriwave enters ICU and related Issue of Shares
March 19, 2025
Quebec Hospital Cuts Spine SSIs by 78%
March 17, 2025
Exercise of Options
March 14, 2025
Seasoned MedTech Exec Appointed as CFO & COO
February 26, 2025
Nasal photodisinfection US market potential
February 19, 2025
Ondine President increases shareholding
February 6, 2025
Ondine CEO increases shareholding
February 4, 2025
Ondine CEO increases ownership
February 3, 2025
CEO Increases Stake in Ondine
January 31, 2025
Notification of Major Holdings
January 30, 2025
Grant of Options and Warrants
January 29, 2025
HCA to invest US$4 million in Ondine
January 27, 2025
Ondine recruits first patient for US Phase 3 trial
December 30, 2024
Ondine commencing US Phase 3 clinical trial
December 17, 2024
Director Holdings
November 22, 2024
Calls
The 5 newest of 9 calls. Every call is listed under its year.
- Ondine Biomedical (LSE:OBI) — Investor Presentation of Phase 3 Topline Results
Sep 10, 2026
Transcript - Ondine Biomedical (LSE:OBI) — Results for the year ended 31 December 2025
Jun 4, 2026
Transcript - Ondine Biomedical (LSE:OBI) — Interim financial results for the period ended 30 June 2025
Sep 26, 2025
Transcript - Ondine Biomedical (LSE:OBI) — Audited results for the year ended 31 December 2024
May 15, 2025
Transcript - Ondine Biomedical (LSE:OBI) — Half Year Results
Sep 30, 2024
Transcript